We get to look at a company whom I’ve always rated quite well, (my last after their Q1 which received 3.5 stars), but I’ve never actually pulled the trigger. I wrote about them a couple of weeks ago in my monthly “What’s Wolf Watching” article.
After a rather tough Q3 which saw revenue drop by 6% and profitability by over 70%, the stock took a beating, but it was starting to trade at very attractive valuations. Instead of repeating my full diatribe, here is what I said then:
So the order intake and backlog, perhaps assisted by tariff frontrunning appears to have delivered a great quarter on the surface. Let’s dig into it.